SynthesisBMJ open ophthalmology2019
Iridoplasty for plateau iris syndrome: a systematic review.
Synthesis in BMJ open ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 15 citations in OpenAlex.
- Quantitative Ultrasound Biomicroscopy Assessment of Anterior Chamber Angle Changes One Year After Laser Peripheral Iridotomy in Primary Angle Closure Suspects.Journal of clinical medicine · 2026Article
- Article
- Peripheral Iris Cerclage in Angle Closure Glaucoma: A Retrospective Pilot Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Effect of mydriasis on anterior segment biometric parameters of patients with age-related cataracts.BMC ophthalmology · 2025Article
- Seeing Beyond the Expected: An Uncommon Case of Plateau Iris Syndrome in the Outpatient Setting.Cureus · 2024Article
- Lens extraction versus laser peripheral iridotomy for acute primary angle closure.The Cochrane database of systematic reviews · 2023Review
- Contemporary Approach to Narrow Angles.Journal of ophthalmic & vision researchReview
- Plateau Iris: A Review.Journal of current ophthalmologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plateau iris syndrome (PIS) is a frequent cause of angle closure. Argon laser peripheral iridoplasty (ALPI) has been proposed in PIS to widen the iridocorneal angle. The objective of the present study was to perform a systematic review of the available studies evaluating the efficacy of ALPI on intraocular pressure (IOP), iridocorneal angle opening and the number of medications in patients with chronic angle-closure associated with PIS. One prospective and seven retrospective studies with a minimum 1 month of follow-up were included. Although ALPI seemed to lower IOP, to decrease the number of topical antiglaucoma medications and widen the iridocorneal angle shortly after the procedure, there is no current evidence of long-term efficacy. To date, there is no robust scientific evidence to advocate ALPI as a treatment for chronic angle-closure caused by PIS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.